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Abstract
Purpose of review—Work-related asthma has been associated with poorer asthma control and 
frequent unscheduled healthcare visits, and can be fatal. Case reports of work-related asthma 
deaths are rare, but can initiate efforts to prevent additional cases. We reviewed relevant literature 
and data sources to evaluate whether analyzing mortality data at the population level can help 
identify potential sources of exposures that contribute to work-related asthma.
Recent findings—A limited number of population-based studies have addressed work-related 
asthma mortality. Data on asthma mortality are derived from death certificates using the 
International Classification of Diseases (ICD) as a standard for coding cause. However, no discrete 
code for work-related asthma is available. Analysis of asthma mortality relative to industries and 
occupations appears to identify high-risk jobs that were not identified by analyzing asthma 
morbidity data.
Summary—Beyond recognized work-related asthma deaths, it is possible that occupational 
exposures have contributed to other asthma deaths that have gone unnoticed and could potentially 
be identified by the analysis of mortality data at the population level. Such analyses in the United 
States appear to assist in recognizing high-risk occupations and industries. Additional analyses 
would be possible if a work-related asthma ICD code were available.
Keywords
morbidity; mortality; work-related asthma
INTRODUCTION
Work-related asthma is a subset of asthma that includes new-onset asthma that is caused by 
factors related to work or the workplace environment (i.e. occupational asthma) and 
preexisting or concurrent asthma that is worsened by factors related to work (i.e. work-
exacerbated asthma) [1,2■]. Work-related asthma has been associated with poorer asthma 
control and frequent unscheduled healthcare visits, and can be a fatal disease [3]. A limited 
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number of population-based studies have addressed work-related asthma mortality and most 
published studies are case reports [4■,5–7]. We reviewed literature and data sources on 
asthma deaths with an emphasis on their relationship to work in order to evaluate whether 
the analysis of population mortality data can help to identify jobs and exposures that 
contribute to work-related asthma.
ASTHMA EPIDEMIOLOGY
Asthma, a chronic and usually inflammatory disorder of the airways, is characterized by 
variable and recurring episodic wheezing, shortness of breath, chest tightness, cough, airflow 
obstruction, and bronchial hyperresponsiveness. It is one of the most prevalent lung diseases 
worldwide with an estimated 235 million people having asthma in 2015 [8]. In the United 
States, an estimated 25.7 million persons had asthma in 2010 [9]. Of these, 18.7 (72.8%) 
million were adults aged at least 18 years. Asthma prevalence among US adults has 
increased from 6.9% in 2001 to 8.2% in 2010 [9]. In 2009, adult asthma resulted in 7.2 
million physician visits, 1.1 million emergency department visits, 600 000 hospital 
outpatient department visits, 299000 hospitalizations, and 3262 deaths in the United States 
[10].
WORK-RELATED ASTHMA
Work-related asthma is a commonly occurring disease and an estimated 16.9% (range 8.6–
44.0%) of adult-onset asthma is attributed to workplace exposures [11]. Among ever-
employed adults with current asthma who participated in the Asthma Call-back Survey in 29 
states in the United States during 2012–2013, an estimated 15.2% had work-related asthma 
and an additional 40.8% had possible work-related asthma [12]. In this study, adults with 
work-related asthma were identified as those who reported having health professional-
diagnosed work-related asthma, and adults with possible work-related asthma were 
identified as those who did not have a health professional-diagnosed work-related asthma 
but reported that their asthma was caused or made worse by chemicals, smoke, dust or mold 
in their current or previous job.
Over 300 factors and agents have been associated with work-related asthma [13]. Lists of 
agents causing work-related asthma are continuously revised as new factors and asthmagens 
are reported [13,14■,15,16]. An updated list of agents that cause occupational asthma with 
key references is available online [17■■]. A 2018 review by Dao and Bernstein [18] 
summarized major causes of occupational asthma and provided a list of occupations that 
place workers at risk. In addition, the authors outlined steps in evaluating patients with 
suspected occupational asthma [18].
Compared with adults with nonwork-related asthma, adults with work-related asthma have 
poorer asthma control [3] and more frequent asthma-related healthcare visits, emergency 
department visits and hospitalizations for a similar level of airflow obstruction and airway 
responsiveness [19]. A recent report indicated that during 2011–2016, an estimated 11 
million (6.8%) adults in the United States employed at any time in the previous year had 
current asthma [20]. Among those, 44.7% (4.9 million) experienced at least one asthma 
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attack, and 9.9% (1.1. million) had at least one asthma-related emergency department visit in 
the previous year. The prevalence of current asthma, asthma attacks, and asthma-related 
emergency department visits was elevated in certain industries and occupations suggesting 
increased risks for these health outcomes associated with workplace exposures [20]. For 
example, among those with current asthma, workers in the education, training, and library 
occupations had the highest (51.5%) prevalence of asthma attacks, and workers in personal 
care and service occupations had the highest (17.4%) prevalence of emergency department 
visits in the past 12 months.
RISK OF ASTHMA ATTACKS AND DEATH
The American Thoracic Society has defined asthma exacerbations as ‘events characterized 
by a change from the patient’s previous status’ [21]. Severe exacerbations may be 
unresponsive to treatment with bronchodilators and corticosteroids and require urgent action 
to prevent hospitalization or death. Workers with asthma may develop asthma exacerbations 
after exposure to allergic or nonallergic (irritant) factors in the workplace [22]. An estimated 
21.5% of adults with asthma experience asthma exacerbations in relation to work [23]. 
Prevention of severe asthma exacerbations is important because exacerbations have been 
associated with an accelerated decline of respiratory function [23,24].
Characteristics of patients with asthma who are at high risk for asthma-related death have 
been summarized by the National Asthma Education and Prevention Program (NAEPP) 
Expert Panel [24]. Risk factors were grouped in three areas related to: asthma history: 
previous severe exacerbation (e.g. requiring intubation or admission to an ICU for asthma), 
two or more hospitalizations for asthma in the past year, three or more emergency 
department visits for asthma in the past year, hospitalization or emergency department visit 
for asthma in the past month, using more than two canisters of short-acting beta agonists per 
month, difficulty perceiving asthma symptoms or severity of exacerbations, lack of a written 
asthma action plan, sensitivity to Alternaria spp.; social history: low socioeconomic status or 
inner-city residence, illicit drug use, major psychosocial problems; and presence of 
comorbidities: cardiovascular disease, other chronic lung disease, chronic psychiatric 
disease. In a 2016 review, D’Amato et al. [25] reported similar risk factors and discussed in 
detail patient characteristics associated with asthma exacerbations and asthma-related 
deaths.
WORK-RELATED ASTHMA DEATH CASE REPORTS
Information on work-related asthma deaths is available from case reports. For example, a 
death from work-related asthma was attributed to exposure to shark cartilage in a mill 
worker, a tragic event that was investigated by the National Institute for Occupational Safety 
and Health (NIOSH) in the United States [6]. In addition, the authors discussed previous 
reports of fatal occupational asthma associated with various agents in printing, 
pharmaceutical industries, food processing, agriculture, foundries, and autobody industries. 
State-based surveillance in the United States has also revealed individual work-related 
asthma deaths. The four states that conducted work-related asthma surveillance during the 
1990s into the 21st century identified cases using multiple data sources (e.g. reports form 
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healthcare providers, hospital discharge data, workers’ compensation data, death certificates) 
[26–28]. Identification of such patients triggers a follow-up investigation, which includes 
evaluating worksite factors potentially responsible for asthma and screening other workers 
for asthma at the implicated worksite. Despite multiple limitations, these systems offer a 
unique opportunity to identify work-related asthma cases and related exposures [27,29]. 
Surveillance in the state of Michigan during 1988–2015 yielded 3417 work-related asthma 
cases. Among these, seven deaths occurred during 1988–2008 [5,7], and one death occurred 
in 2015 [28]. The relevant exposures included an isocyanate-containing polyurethane bed 
liner material that a worker sprayed inside a van [5], and workplace secondhand tobacco 
smoke exposure experienced by a waitress [7]. Folletti et al. [30] in their review of published 
articles on cleaning agents and asthma identified reports of inhalation accidents in cleaners 
associated with acute irritant-induced asthma and work-exacerbated asthma [31], but no 
studies reported on work-related asthma deaths attributed to cleaning agents.
As illustrated by the surveillance data from Michigan, work-related asthma deaths are rare: 
only 8 of 3417 (0.23%) work-related asthma cases resulted in death. However, the extreme 
nature of these events often stimulates a series of alerts, fact sheets, and publications that 
have the goal of preventing workers from experiencing similar exposures and outcomes. For 
example, the February 2003 asthma death of a worker in Michigan after spraying an 
isocyanate-containing bed liner inside a cargo van was followed by a series of notices and 
articles. The Michigan Fatality Assessment and Control Evaluation (MIFACE) program 
conducted an investigation and generated a case report [32] and the state work-related 
asthma surveillance program published a summary in an autumn 2003 newsletter [33]. The 
Washington State Department of Labor and Industries published a related Hazard Alert in 
March 2003, [34]a Hazard Alert Update in February 2004 [35], and a guide for safe 
application of spray on truck bed liners in June 2004 [36]. A report of the Michigan case 
appeared in the peer-reviewed medical literature in 2005 [5]. Also, a column on OSHA 
Compliance Issues addressed this issue in a professional journal in March 2006 [37]. In 
September 2006, NIOSH published an alert [38] and a related fact sheet [39] about 
preventing asthma and death among workers who spray the truck bed liners. During the 
same era, the Washington State Department of Labor and Industries published peer-reviewed 
articles about measured levels of methylene-diphenyl isocyanate (MDI) exposure 
experienced by workers in the spray-on truck bed lining industry [40] and a description of 
work-related asthma cases attributed to MDI exposure in this industry that received workers’ 
compensation [41].
It is possible that case reports and cases identified via surveillance are unable to fully reveal 
the occupational contribution to asthma mortality as the association of an asthma death with 
occupational exposures can go unnoticed [42–46]. For example, previous studies reported 
that some physicians take inadequate occupational histories from their asthma patients and 
do not refer suspected cases to occupational medicine or pulmonary physicians for 
additional evaluation [42,43]. In a 2013 study, 4.7% of incident asthma cases reported their 
healthcare professional told them they had work-related asthma, but when self-identified 
cases of work-related asthma were considered as well the proportion was 18.2% [45]. With 
this in mind, the analysis of mortality data at the population level has the potential to fill in 
gaps left by other data sources, and therefore contribute to prevention.
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ASTHMA MORTALITY DATA SOURCE
The primary source of information on asthma mortality at the population level are death 
certificates and the International Classification of Diseases (ICD) is the international 
standard for reporting causes of death [47,48]. Depending on the adopted revision, 
researchers use relevant codes for identifying asthma deaths and assessing trends [25,49–
59]. In general, each successive revision expands disease categories to provide more detailed 
information. For example, ICD 9th revision (ICD-9) provides a single code for asthma (493) 
whereas ICD 10th revision (ICD-10) provides two codes (J45, asthma; and J46, status 
asthmaticus). In the United States, multiple-cause mortality data are available on an annual 
basis beginning with data year 1968, and they are classified according to the ICD-10 starting 
with data year 1999.
The ICD-10 was recently reviewed for modifications and the 11th revision is currently 
available on the WHO web site [47]. In the ICD-11, the CA23 code for asthma includes 
expanded categories for allergic and nonallergic asthma (with subcategories for asthma 
exacerbation and status asthmaticus), other forms of asthma or bronchospasm (including 
aspirin-induced asthma and exercise-induced bronchospasm), and unspecified asthma. No 
discrete code for work-related asthma is available.
Death certificates include information on the causal chain of morbid conditions that led to 
death [60]. When two or more causes are recorded on the certificate, the underlying cause of 
death defined as ‘the disease or injury which initiated the train of morbid events leading 
directly to death, or the circumstances of the accident or violence which produced the fatal 
injury’ is selected. Any cause of death that is neither the direct, intervening, originating 
antecedent nor underlying is considered a contributing cause of death [47,60].
MORTALITY DATA LIMITATIONS
Previous studies examined the quality of information from death certificates [61] and 
researchers recognize data limitations in studying asthma mortality [48]. Frequently 
mentioned is a lack of cause of death validation against medical records and the possibility 
of misclassification. For example, asthma deaths might be mistakenly classified as COPD 
[52,55,57]. Moreover, asthma may be under-ascertained as a cause of death, in particular in 
an older population [55,56]. Other important issues are limited comparability and accuracy 
of cause-of-death statistics for assessing trends over time when new ICD versions or 
revisions are introduced [48,58,61,62]. Anderson et al. conducted a comparability study for 
113 selected causes of death between ICD-9 and ICD-10 for the United States [62]. For 
asthma, the authors found a comparability ratio of 0.8855 [63] indicating that asthma was 
less likely to be selected as the underlying cause of death in ICD-10 than in ICD-9.
As underlying cause-of-death data may underestimate the burden of asthma-related 
mortality, some researchers have examined deaths for which asthma was listed on the death 
certificate as either the underlying or a contributing cause of death (i.e. identifying any 
mention of the disease) [49,56]. For example, McCoy et al. [56] found that 45% of all 
asthma-related deaths in the United States reported for 1990–2001 had asthma listed as the 
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underlying cause of death. A similar proportion (42%) was reported by Fuhrman et al. [49] 
using French mortality data for 2004–2005. The authors of both studies indicated that using 
multiple-cause of death allows for a better understanding of asthma mortality burden and 
interpretation of mortality trends when the rules for assigning the underlying cause change 
[49,56].
None of the ICD revisions includes a distinct code for work-related asthma. Thus, trends in 
work-related asthma deaths cannot be assessed directly. Steenland et al. [64], estimated that 
11–21% of asthma deaths might be attributable to occupational exposures. Using this 
estimate and the US National Vital Statistics System’s multiple cause-of-death data for 
1999–2016, Patel et al. reported that among persons aged 15–64 years, 3664–6994 asthma 
deaths might be attributable to occupational exposures during 1999–2016 (1573–3002 
among men and 2091–3992 among women) [4■]. Despite the authors’ findings that the 
annual age-adjusted asthma death rate per 1 million persons declined from1999 to 2016, 
they could not assess the trend in work-related asthma deaths because of the absence of a 
separate ICD code for work-related asthma.
The lack of information on asthma deaths in relation to work was evident in other studies 
[49,56,65]. For example, Gullach et al. [65] reviewed Danish 2000–2006 sudden death cases 
that occurred in persons aged 1–35 years with uncontrolled asthma, using death certificates, 
medical records, and autopsy reports to identify cases. Among 625 sudden deaths, 49 (8%) 
decedents had uncontrolled asthma. An acute asthma attack was identified as a cause of 
death in 13 (27%) of the 49. Remaining deaths were attributed to sudden cardiac death. 
Although the location of death for 17 decedents was a public place, no additional 
information on work-relatedness of these deaths was reported.
COMPARING ASTHMA MORBIDITY AND MORTALITY
In evaluating working adults with asthma, it is important to determine whether occupational 
exposures have contributed to the onset or exacerbation of symptoms [22]. Death certificates 
are not designed to collect this information. Alternatively, information from records for 
emergency department visits and hospital stays might be a valuable source for determining 
work-relatedness of asthma deaths [66]. A recent study in the United States reported an 
increased prevalence of asthma, asthma attacks, and emergency room visits for asthma 
among workers in certain industries and occupations [20]. These findings might be because 
of occupational exposures or self-selection of people with asthma into jobs they might 
consider free from exposure to asthmagens [67]. Moreover, in US studies, a disproportionate 
number of workers with asthma, especially in certain industries and occupations, may have 
inadequate or possibly no health insurance coverage [68]. These workers may have poorly 
managed and controlled asthma and may be more likely to have unscheduled healthcare 
visits.
Examining data from two recently published US studies revealed similarities and differences 
between asthma morbidity [20] and mortality [4■] relative to industries and occupations. An 
important caveat is that the two studies presented data for somewhat different categories of 
industries and occupations, which prevented a more complete comparison of the two types 
Mazurek and Henneberger Page 6
Curr Opin Allergy Clin Immunol. Author manuscript; available in PMC 2020 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
of data. Nevertheless, elevated proportionate mortality ratios (PMRs) for asthma were 
matched by elevated prevalence estimates for the social assistance (workers in this industry 
provide a wide variety of social assistance services directly to their clients) and healthcare 
industries (Table 1). By occupation, the elevated PMRs were matched by elevated 
prevalence estimates for healthcare support occupations, and office and administrative 
support occupations. However, in miscellaneous manufacturing industries, elevated PMRs 
were not matched by elevated asthma prevalence estimates. Similarly, elevated PMRs by 
occupation were not matched by elevated prevalence estimates for community and social 
services occupations, and sales and related occupations. The finding of elevated asthma 
mortality concurrent with morbidity that is not elevated suggests that the excess deaths are 
not the result of adults with asthma purposely selecting a job to avoid troublesome 
workplace exposures. This would be especially true for the industry category of 
miscellaneous manufacturing, which has an elevated PMR matched with an asthma 
prevalence of 4.8% that is less than the overall estimate of 6.8%. In summary, these 
comparisons of morbidity and mortality data suggest that when examining data by industry 
and occupation, asthma-specific mortality might indicate potential problems with workplace 
exposures and access to appropriate asthma care that are not revealed by asthma-specific 
morbidity.
CONCLUSION
Early identification of work-related asthma cases and workplace follow-up could prevent 
asthma-related cases and deaths [1,2■,24,26]. The analysis of mortality data at the 
population level appears to add insight regarding potential sources of exposure that 
contribute to work-related asthma, complementing existing reports of asthma morbidity and 
mortality. However, the magnitude of asthma mortality in relation to work cannot be 
sufficiently recognized as no discrete code for work-related asthma is available in the ICD.
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KEY POINTS
• Case reports of work-related asthma deaths remain a focus of preventive 
efforts because they serve as sentinel events.
• The analysis of asthma mortality data at the population level may help to 
identify sources of exposure that contribute to work-related asthma.
• It is not possible to estimate the full magnitude of asthma mortality in relation 
to work because no discrete code for work-related asthma is available in the 
current International Classification of Diseases.
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